Effect of atropine on gastro-oesophageal reflux and transient lower oesophageal sphincter relaxations in patients with gastro-oesophageal reflux disease
I Lidums
a Department of
Gastrointestinal Medicine, Royal Adelaide Hospital, Adelaide, South
Australia, b Gastroenterology Division, University of
Virginia Health Sciences Center, Charlottesville, VA, USA
Correspondence to: Dr R Holloway, Department of Gastrointestinal Medicine, Royal
Adelaide Hospital, North Terrace, Adelaide, SA 5000, Australia. Accepted for publication 4 February 1998 Background Keywords:
gastro-oesophageal reflux;
lower oesophageal
sphincter;
manometry;
diaphragm;
atropine;
pharmacology
Atropine
reduces the rate of reflux episodes in normal subjects by inhibition of
transient lower oesophageal sphincter (LOS) relaxations. The aim of
this study was to investigate the effect of atropine on the rate and
mechanisms of reflux in patients with reflux disease.
Methods
Oesophageal
motility and pH were recorded for one hour after a meal in 15 patients
with reflux disease. On separate days, atropine (15 µg/kg bolus
intravenously, 4 µg/kg/h infusion) or saline were given and
maintained for the recording period.
Results
Atropine
significantly reduced basal LOS pressure from 7.1 (2.2) to 2.9 (1.3) mm
Hg (mean (SEM)). Atropine also reduced the rate of reflux episodes from
5.0 (2.0-8.75) to 1.0 (0-6.25) per hour (median (interquartile
range)) largely because of a decrease in the rate of transient LOS
relaxations from 2.0 (0-4.75) to 0 (0-0) per hour and abolition of
reflux during swallow induced LOS relaxation. There was no change in
the rate of reflux episodes because of absent basal LOS pressure.
Conclusions
Atropine
inhibits reflux in patients with reflux disease largely by inhibition
of transient LOS relaxations and swallow induced LOS relaxation. These
findings suggest that pharmacological control of reflux through control
of transient LOS relaxations is possible in patients with reflux disease.
(GUT 1998;43:12-16)
© 1998 by Gut
This article has been cited by other articles:
-
Zhang, Q., Horowitz, M., Rigda, R., Rayner, C., Worynski, A., Holloway, R. H.
(2004). Effect of hyperglycemia on triggering of transient lower esophageal sphincter relaxations. Am. J. Physiol. Gastrointest. Liver Physiol.
286: G797-G803
[Abstract] [Full Text] -
Ciccaglione, A F, Marzio, L
(2003). Effect of acute and chronic administration of the GABAB agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease. Gut
52: 464-470
[Abstract] [Full Text] -
Liu, J., Pehlivanov, N., Mittal, R. K.
(2002). Baclofen blocks LES relaxation and crural diaphragm inhibition by esophageal and gastric distension in cats. Am. J. Physiol. Gastrointest. Liver Physiol.
283: G1276-G1281
[Abstract] [Full Text] -
Zhang, Q, Lehmann, A, Rigda, R, Dent, J, Holloway, R H
(2002). Control of transient lower oesophageal sphincter relaxations and reflux by the GABAB agonist baclofen in patients with gastro-oesophageal reflux disease. Gut
50: 19-24
[Abstract] [Full Text] -
Lidums, I, Hebbard, G S, Holloway, R H
(2000). Effect of atropine on proximal gastric motor and sensory function in normal subjects. Gut
47: 30-36
[Abstract] [Full Text] -
Fang, J C, Sarosiek, I, Yamamoto, Y, Liu, J, Mittal, R K
(1999). Cholinergic blockade inhibits gastro-oesophageal reflux and transient lower oesophageal sphincter relaxation through a central mechanism. Gut
44: 603-607
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
